Is It Still Safe To Buy Aviva Plc?

In this strong market, should you still buy Aviva plc (LON: AV)?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I’m always searching for shares that can help ordinary investors like you make money from the stock market. However, many people are currently worried the market has been overheating.

So right now I’m analysing some of the most popular companies in the FTSE 100, hoping to establish if they can continue to outperform in today’s uncertain economy.

Today I’m looking at insurer Aviva (LSE: AV) (NYSE: AV.US) to determine whether the shares are still safe to buy at 367p.

So, how’s business going?

Aviva is currently undertaking a huge turnaround programme aimed at cutting costs, reducing the group’s exposure to Europe and simplifying the company’s overall structure.

Indeed, it would appear that the company is already making progress, as within Aviva’s first-quarter management statement, the company noted that operating expenses had fallen by £83m or 10% year-on-year — more than 20% of the company’s total targeted cost saving of £400m.

In addition, during the same three-month period, Aviva reduced internal debt by £300m and the value of new business taken on by the company rose 18%.

Furthermore, in an attempt to simplify the business, four levels of middle management were removed. 

That said, Aviva’s operations within southern Europe continued to show weakness and the value of business written in Spain and Italy dropped 67% and 56% respectively during the quarter.

Expected growth

Unfortunately, Aviva reported a loss during 2012 but many City analysts expect the company’s earnings to rebound this year. City forecasts currently predict earnings of 41.4p per share for this year (up from -15.2p during 2012) and 46.4p for 2014.

Shareholder returns

Aviva was well known for its larger-than-average dividend yield; however, the company was forced to cut its payout earlier this year, citing cash flow problems.

Still, even after the dividend cut, Aviva supports a yield of 5.2% — larger than that of its peers in the life insurance sector, which currently offer an average dividend yield of 3.7%.

Valuation

As Aviva made a loss during 2012, it is not possible for me to calculate a historic P/E for the company.

Having said that, based on estimates for future earnings, I believe the group is currently trading at a forward P/E ratio of 8.7, cheaper than the company’s peers in the life insurance sector, which are currently trading at a historic P/E of around 14.1.

Foolish summary

All in all, based on the company’s progress during the first quarter of this year, above average dividend yield and discount to sector peers, I feel that Aviva still looks safe to buy at 367p.

More FTSE opportunities

As well as Aviva, I am also positive on the five FTSE shares highlighted within this exclusive wealth report.

Indeed, all five opportunities offer a mix of robust prospects, illustrious histories and dependable dividends, and have just been declared by the Fool as “5 Shares You Can Retire On“!

Just click here for the report — it’s free.

In the meantime, please stay tuned for my next FTSE 100 verdict

> Rupert does not own any share mentioned in this article.

More on Investing Articles

British pound data
Investing Articles

Starting with nothing? Here’s why now is the perfect time to start building a passive income

Many are worried that 2026 might be a bad time to start investing in stocks and shares. Our Foolish author…

Read more »

ISA coins
Investing Articles

Decided not to bother with a Stocks and Shares ISA? You might be missing these 3 things!

With a fresh annual allowance for contributing to a Stocks and Shares ISA upon us, what might people who don't…

Read more »

GSK scientist holding lab syringe
Investing Articles

Why is everyone buying GSK shares?

GSK shares have been outperforming the FTSE 100 in 2026. Paul Summers takes a closer look and asks whether this…

Read more »

Middle-aged white man pulling an aggrieved face while looking at a screen
Investing Articles

£10,000 invested in easyJet shares at the start of 2026 is now worth…

Anyone buying easyJet shares will have endured a rough ride since January. Paul Summers wonders whether things could get even…

Read more »

Close-up of a woman holding modern polymer ten, twenty and fifty pound notes.
Investing Articles

5 years ago, £5,000 bought 2,645 Barclays shares. But how many would it buy now?

Despite delivering an impressive return since April 2021, Barclays' shares have lagged the FTSE 100's other banks. James Beard considers…

Read more »

Side of boat fuelled by gas to liquids, advertising Shell GTL Fuel
Investing Articles

5 years ago, £5,000 bought 354 Shell shares. But how many would it buy now?

When it comes to Shell’s numbers, most of them are impressive. And it’s no different when looking at the recent…

Read more »

A rear view of a female in a bright yellow coat walking along the historic street known as The Shambles in York, UK which is a popular tourist destination in this Yorkshire city.
Investing Articles

I asked ChatGPT if I should buy Aviva, Diageo or BAE Systems stock and it said…

Aviva, Diageo and BAE Systems shares are popular FTSE 100 picks. But which of the three does ChatGPT like the…

Read more »

Tesla car at super charger station
Investing Articles

SpaceX’s IPO threatens to leave the Tesla share price on the forecourt

As Elon Musk starts fuelling the engines for a SpaceX IPO, could the Tesla share price get left in the…

Read more »